14 October 2022>: Clinical Research
Correlation Between Trough Level of Abiraterone and Prostate-Specific Antigen (PSA) Response in Metastatic Hormone-Sensitive Prostate Cancer
Zin W. Myint 12ABCDEFG* , Jill M. Kolesar 23CDE , Joseph Robert McCorkle 2CDE , Jianrong Wu 4C , Carleton S. Ellis 23CDE , Danielle E. Otto 23CDE , Peng Wang 12ACDEDOI: 10.12659/MSM.938091
Med Sci Monit 2022; 28:e938091
Table 8 Association between HSD3B1 genotype risk-allele and survival outcomes (overall survival and response).
Risk allele | P value | ||
---|---|---|---|
Yes | No | ||
Alive | |||
Yes | 4 | 35 | 0.79 |
No | 2 | 1 | |
Survival response | |||
Yes (CR, PR) | 2 | 3 | 0.22 |
No (SD, PD) | 4 | 1 | |
OS – overall survival; CR – complete response; PR – partial response; SD – stable disease; PD – progressive disease. |